Your browser doesn't support javascript.
loading
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.
Giossi, Riccardo; Consonni, Alessandra; Torri Clerici, Valentina; Zito, Antonio; Rigoni, Eleonora; Antozzi, Carlo; Brambilla, Laura; Crisafulli, Sebastiano Giuseppe; Bellino, Antonella; Frangiamore, Rita; Bonanno, Silvia; Vanoli, Fiammetta; Ciusani, Emilio; Corsini, Elena; Andreetta, Francesca; Baggi, Fulvio; Tramacere, Irene; Mantegazza, Renato; Conte, Antonella; Bergamaschi, Roberto; Confalonieri, Paolo.
Afiliación
  • Giossi R; Department of Oncology and Onco-Hematology, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan, Via Vanvitelli 32, Milan 20129, Italy; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, I
  • Consonni A; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Torri Clerici V; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Zito A; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
  • Rigoni E; Multiple Sclerosis Centre, IRCCS Mondino Foundation, Via Mondino 2, Pavia 27100, Italy.
  • Antozzi C; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Brambilla L; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Crisafulli SG; Department of Human Neurosciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.
  • Bellino A; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Frangiamore R; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Bonanno S; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Vanoli F; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy; Department of Human Neurosciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.
  • Ciusani E; Laboratory of Neurological Biochemistry and Neuropharmacology, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Corsini E; Laboratory of Neurological Biochemistry and Neuropharmacology, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Andreetta F; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Baggi F; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Tramacere I; Department of Research and Clinical Development, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Mantegazza R; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
  • Conte A; Department of Human Neurosciences, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy; IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy.
  • Bergamaschi R; Multiple Sclerosis Centre, IRCCS Mondino Foundation, Via Mondino 2, Pavia 27100, Italy.
  • Confalonieri P; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Via Celoria 11, Milan 20133, Italy.
Mult Scler Relat Disord ; 58: 103415, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35216790

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos